Imiquimod 5% tópico como terapia alternativa en carcinoma basocelular periocular en 2 pacientes con contraindicación quirúrgica

  1. C. Costales-Álvarez
  2. M. Álvarez-Coronado
  3. P. Rozas-Reyes
  4. C.M. González-Rodríguez
  5. L. Fernández-Vega
Aldizkaria:
Archivos de la Sociedad Española de Oftalmologia

ISSN: 0365-6691

Argitalpen urtea: 2017

Alea: 92

Zenbakia: 2

Orrialdeak: 93-96

Mota: Artikulua

DOI: 10.1016/J.OFTAL.2016.07.002 DIALNET GOOGLE SCHOLAR

Beste argitalpen batzuk: Archivos de la Sociedad Española de Oftalmologia

Garapen Iraunkorreko Helburuak

Laburpena

Clinical cases The cases are presented of two patients with periocular basal cell carcinoma of the eyelid who received topical imiquimod 5%, with a good response. Both had a functional state that contraindicated surgical treatment. Conclusion Imiquimod cream 5% was shown to be an effective alternative to surgical treatment of periocular basal cell carcinoma, especially in those cases where surgery is not possible.

Datuen iturria: Dialnet